Introduction
============

The change in body composition of post-menopausal women is considered a result of long-term interactions among energy intake, energy expenditure, and sex hormonal status or a combination thereof [@B1], [@B2], [@B3], [@B4],[@B5]. Menopause is frequently associated with increased central (visceral) body fat [@B6],[@B7], followed by an increasing incidence of hypertension [@B8] and the aggravation of the lipoprotein profile [@B9], which lead to metabolic syndrome [@B10] and the subsequent rise in the incidence of cardiovascular diseases [@B11]. During menopausal transition, women experience deleterious changes in circulating inflammatory markers and adipokines correlated with increased visceral adiposity [@B12]. A growing number of evidence has demonstrated that chronic low-grade/subclinical inflammation is a key element in the development of atherosclerotic cardiovascular disease and is closely associated with obesity, insulin resistance, and metabolic syndrome [@B13],[@B14],[@B15],[@B16].

Dietary protein plays a role in controlling body weight, which is partially attributed to its effects on satiety. Among common dietary proteins, purified collagen hydrolysate has been clinically proven as an effective appetite suppressant that maintains a satiating effect to promote weight loss [@B17],[@B18]. Insoluble fibrous protein collagen, the single most abundant protein in animals, is the major component of the extracellular matrix and connective tissues. At least 16 types of collagen have been identified in humans; among these, 80%-90% belong to types I, II, and III collagen. Although supplementing with collagens and their derived peptides has been demonstrated to improve cellulite and skin health [@B19], whether collagen hydrolysate supplementation affects menopause-induced obesity remains unclear.

In the present study, we aimed to investigate the effects of collagen hydrolysate supplementation on estrogen deficiency-induced obesity by using an ovariectomized (OVX) animal model. The body weight, uterus weight, fat mass, and serum biochemical factors of OVX rats were assessed. Adipocyte size was also determined.

Materials and Methods
=====================

Reagents
--------

All chemicals used were obtained from Sigma-Aldrich (St. Louis, MO, USA) except when otherwise specified. Collagen hydrolysate was purchased from KVW Health Co. Ltd. (Taipei, Taiwan).

Ovariectomized rat model
------------------------

All female Sprague-Dawley rats weighing approximately 200 g were purchased from the National Laboratory Animal Center (Taipei City, Taiwan) and maintained under the supervision of the Institutional Animal Care and Use Committee (IACUC) of the China Medical University. Animal experiment protocol was approved by the IACUC and performed in accordance with the guidelines.

For estrogen deficiency-induced obesity and collagen supplementation, 24 rats were divided into 4 groups for sham operation (group 1) and OVX operation (groups 2-4). Operation was performed under Nembutal (Pentobarbital sodium, 50 mg/kg body weight) anesthesia. Groups 1 and 2 were supplied with sterile water. Groups 3 and 4 were supplied with sterile water containing 1.25 mg/mL and 2.5 mg/mL collagen hydrolysate, respectively. All animals were maintained under 12 h/12 h light-dark cycles at controlled temperature (22 ± 0.5 ºC) and humidity (45%-50%). Body weight was measured daily at a specified time during the experiment. At the end of the experiment, blood and perigonadal adipose tissue were immediately obtained after the animals were sacrificed. The dorsal fat and uterus of each rat were dissected and weighed.

Histological analysis of adipose tissue and cell size determination
-------------------------------------------------------------------

The perigonadal adipose tissues were fixed in zinc formaldehyde overnight at 4 °C and transferred into phosphate-buffered saline. The fixed tissues were then embedded into paraffin, sectioned, and stained with hematoxylin and eosin. Digital images were captured at 200× magnitude using an Olympus DX51 light microscope (Tokyo, Japan).

Measurement of serum biochemical makers
---------------------------------------

The blood was coagulated by maintaining it at room temperature for 15-20 min, followed by centrifugation for 10 min. The indicated parameters (calcium ions, glucose, inorganic phosphorus, total cholesterol, and triacylglycerol) were measured using a serum biochemistry analyzer (AU400, Olympus, Tokyo, Japan).

Statistical analysis
--------------------

Data were expressed as means ± standard error. Statistical comparisons were made via ANOVA test using a statistical software (SigmaStat 3.5, Systat Software, Inc. San Jose, CA, USA).

Results
=======

Collagen supplementation reduced OVX-associated increase in body weight but not uterine weight
----------------------------------------------------------------------------------------------

The effects of collagen uptake on estrogen deficiency-induced obesity were initially investigated. The increase in body weight of OVX rats (OVX) was significantly higher than that of sham-operated control rats (Sham) (P\<0.01) (Figure [1](#F1){ref-type="fig"}A). After 12 weeks, the body weights of the Sham and OVX groups were 315 ± 7 g and 365 ± 16 g, respectively. The increase in body weight of the OVX with 2.5 mg/mL collagen supplement group was significantly lower than that of the OVX group but not that of the OVX with 1.25 mg/mL collagen supplement group (P\<0.05).

Change in uterus weight in response to collagen supplementation was also monitored. The ratio of uterus/body weight in the OVX group significantly decreased compared with that of the Sham group (P\<0.05) (Fig. [1](#F1){ref-type="fig"}B). Interestingly, the ratio of uterus/body weight in the OVX with collagen supplement groups (OVX+1.25C and OVX+2.5C) significantly decreased compared with that of the Sham group (P\<0.01) but was insignificantly altered compared with that of OVX group.

Collagen supplementation decreased OVX-associated increase in adipocyte size
----------------------------------------------------------------------------

Collagen supplementation attenuated weight gain in OVX rats. Therefore, whether supplementation affected adipocyte properties was investigated. Adipocytes in the perigonadal adipose tissue from the OVX rats were clearly enlarged compared with those from the sham-operated control rats (Figure [2](#F2){ref-type="fig"}A). In addition, high collagen supplementation (2.5 mg/mL) reduced the enlarged adipocyte size in response to OVX treatment (Figure [1](#F1){ref-type="fig"}A, OVX+2.5C). Parallel with adipocyte size, the change in dorsal fat mass was analyzed. Although the dorsal fat mass in the OVX group appeared to be higher than that in the Sham group, the ratio of dorsal fat mass/body weight was insignificantly altered among the four experiment groups (Figure [2](#F2){ref-type="fig"}B).

Effects of collagen on blood biochemical factors
------------------------------------------------

To clarify whether collagen supplementationt regulated lipid metabolism, the levels of blood lipids, total cholesterol, and triacylglycerol were determined. As shown in Figure [3](#F3){ref-type="fig"} (upper panel), serum total cholesterol level was slightly regulated in the OVX and OVX with collagen supplement groups (P\>0.05). A similar phenomenon was observed in serum triacylglycerol level (Figure [3](#F3){ref-type="fig"}, lower panel). In addition to blood lipids, other blood biochemical factors were monitored. The levels of serum calcium, phosphorus, and glucose were not altered in response to OVX treatment or OVX with collagen supplements (Figure [4](#F4){ref-type="fig"}).

Discussion
==========

Longitudinal studies have demonstrated a high risk of developing impaired glucose tolerance [@B20], type 2 diabetes [@B20],[@B21], and coronary heart disease [@B22],[@B23],[@B24] in subjects with visceral adiposity. Accordingly, visceral adiposity may have a significant pathophysiological role in the development of metabolic syndrome and its sequelae. Our findings showed that high collagen supplementation (2.5 mg/mL) significantly attenuated weight gain and reduced adipocyte enlargement in response to estrogen deficiency, thereby indicating that collagen supplementation is beneficial for menopause-induced obesity. Furthermore, collagen supplementation may also ameliorate the health of menopausal women by reducing risk factors attributed to menopause-induced obesity.

A previous study has reported that protein intake can prevent muscle mass loss associated with weight loss in obese older women [@B25]. Another study reports that using gelatin as a single diet protein results in appetite suppression in adults, which is more significant than using casein [@B26]. A recent review that investigated the effects of dietary protein intake on body composition changes also indicates that consuming high-protein diets contributes to the maintenance of lean mass and the loss of fat mass during weight loss in older adults [@B27]. Our findings indicate that supplementing with collagen hydrolysate, the digested gelatin, attenuates body weight gain and adipocyte enlargement in OVX rats. Collagen hydrolysate supplementation may not only alleviate menopause-induced obesity but also ameliorate muscle mass maintenance during menopause.

In obesity model animals, the association of abnormal fat mass has not been precisely investigated. [@B28] reported that fat mass was higher in obese, diabetic, leptin-resistant Zucker rats than in their homozygous lean controls. OVX treatment in rodents also leads to weight gain and fat deposition, whereas estradiol treatment restores these changes [@B29],[@B30]. Our results show that collagen supplementation exhibits bioactivity in reducing body weight and adipocyte size similar to that of estradiol treatment. Thus, collagen supplementation may synergically act with estradiol to reduce the use of estradiol and consequently alleviate its side effects.

Conclusion
==========

Our study provides evidence that collagen supplementation can attenuate body weight gain and decrease enlarged adipocyte size. Our findings also indicate that collagen supplementation insignificantly affects the levels of blood lipids, calcium, phosphorus, and glucose. Thus, collagen supplementation can complete its anti-obesity activity with minor side effects in menopausal women.
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![Effects of collagen supplement on body weights. Rats were sham-operated or OVX, and then the OVX-rats were supplied with water containing collagen (1.25 and 2.5 mg/mL, 1.25C and 2.5C) or not. (A) Body weight was measured every week for 12 weeks. (B) After 12 weeks, rats were sacrificed, and then uteruses were obtained and weighed. \#, P\<0.05 as compared to Sham. \*, P\<0.05 as compared to OVX.](ijmsv13p0853g001){#F1}

![Effects of collagen supplement on adipocyte size and dorsal fat content. Rats were sham-operated or OVX, and then the OVX-rats were supplied with water containing collagen (1.25 and 2.5 mg/mL, 1.25C and 2.5C) or not. After 12 weeks, the rats were weighed, and then sacrificed to obtain periuterine adipose tissue and dorsal fat. (A) After H&E staining, the adipocytes were observed by using light microscope (200x). (B) Dorsal fat samples were collected and weighed.](ijmsv13p0853g002){#F2}

![Collagen supplement insignificantly affected blood lipids. Rats were sham-operated or OVX, and then the OVX-rats were supplied with water containing collagen (1.25 and 2.5 mg/mL, 1.25C and 2.5C) or not. After 12 weeks, blood samples were obtained for determination of serum total cholesterol and triacylglycerol. n.s., no statistical significance as compared to Sham or OVX.](ijmsv13p0853g003){#F3}

![Collagen supplement insignificantly affected blood lipids. Rats were sham-operated or OVX, and then the OVX-rats were supplied with water containing collagen (1.25 and 2.5 mg/mL, 1.25C and 2.5C) or not. After 12 weeks, sera were obtained for determination of calcium, phosphorus and glucose level. n.s., no statistical significance as compared to Sham or OVX.](ijmsv13p0853g004){#F4}
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